Protocol Ledger

NCT05006482 · Phase III · RECRUITING

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Interventional Phase III clinical trial protocol NCT05006482 sponsored by University of Rochester in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-03-21 Enrollment: 668 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05006482
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)668 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05006482
Protocol FieldVerified Registry Value
NCT IdentifierNCT05006482
Consolidated Lead SponsorUniversity of Rochester
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment668 participants (ESTIMATED)
Registered Start Date2023-03-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI